These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3032375)

  • 21. [3H]tryptamine binding to reconstituted fraction of acidic lipids.
    Karasawa A; Ogihara M; Ishitani R
    J Pharmacobiodyn; 1987 Feb; 10(2):78-84. PubMed ID: 3598846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative autoradiography of [3H]norharman [( 3H]beta-carboline) binding sites in the rat brain.
    Pawlik M; Kaulen P; Baumgarten HG; Rommelspacher H
    J Chem Neuroanat; 1990; 3(1):19-24. PubMed ID: 2156525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of intranigral administration of 6-hydroxydopamine and 5,7-dihydroxytryptamine on rat brain tryptamine.
    Juorio AV; Greenshaw AJ; Nguyen TV
    J Neurochem; 1987 May; 48(5):1346-50. PubMed ID: 3104539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kynuramine: high affinity for [3H]tryptamine binding sites.
    Charlton KG; Johnson TD; Maurice RW; Clarke DE
    Eur J Pharmacol; 1984 Nov; 106(3):661-4. PubMed ID: 6519183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Interaction of indoleamines with serotonergic receptors of brain synaptosomes].
    Uzbekov MG; Bernshtein KhG
    Biokhimiia; 1980 Jan; 45(1):109-12. PubMed ID: 7213827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacology of harmalan (1-methyl-3,4-dihydro-beta-carboline).
    Rommelspacher H; Brüning G; Susilo R; Nick M; Hill R
    Eur J Pharmacol; 1985 Mar; 109(3):363-71. PubMed ID: 2580722
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of deuterium substitution on the disposition of intraperitoneal tryptamine.
    Dyck LE; Boulton AA
    Biochem Pharmacol; 1986 Sep; 35(17):2893-6. PubMed ID: 3741480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The oxidation of tryptamine by the two forms of monoamine oxidase in human tissues.
    Sullivan JP; McDonnell L; Hardiman OM; Farrell MA; Phillips JP; Tipton KF
    Biochem Pharmacol; 1986 Oct; 35(19):3255-60. PubMed ID: 3094536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Interaction of the anxiolytic agent buspirone with serotonin and other synaptic receptors in the human brain].
    Korneev AIa; Faktor MI; Chan TB
    Biull Eksp Biol Med; 1988 Jan; 105(1):41-3. PubMed ID: 2892547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relative selectivity of some conformationally constrained tryptamine analogs at 5-HT1, 5-HT1A and 5-HT2 recognition sites.
    Taylor EW; Nikam S; Weck B; Martin A; Nelson D
    Life Sci; 1987 Oct; 41(16):1961-9. PubMed ID: 3657392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tryptamine: a neuromodulator or neurotransmitter in mammalian brain?
    Jones RS
    Prog Neurobiol; 1982; 19(1-2):117-39. PubMed ID: 6131482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N-bromoacetyl 5-methoxytryptamine: an irreversible melatonin ligand?
    Chong NW; Evans JE; Sugden D
    Biochem Biophys Res Commun; 1993 Jun; 193(3):1355-61. PubMed ID: 8391805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Butanol extracts from myelin fragments: tryptamine binding to lipid fractions.
    Karasawa A; Kim S; Ishitani R
    Jpn J Pharmacol; 1983 Feb; 33(1):181-7. PubMed ID: 6876516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High affinity (3H)tryptamine binding sites in various organs of the rat.
    Brüning G; Rommelspacher H
    Life Sci; 1984 Apr; 34(15):1441-6. PubMed ID: 6708741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tryptamine concentrations in areas of 5-hydroxytryptamine terminal innervation after electrolytic lesions of midbrain raphe nuclei.
    Juorio AV; Greenshaw AJ
    J Neurochem; 1985 Aug; 45(2):422-6. PubMed ID: 2409228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug antagonism and reversibility of the binding of indoleamines in brain.
    Ungar F; Hitri A; Alivisatos SG
    Eur J Pharmacol; 1976 Mar; 36(1):115-25. PubMed ID: 1063074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional interactions of 2-phenylethylamine and of tryptamine with brain catecholamines: implications for psychotherapeutic drug action.
    Greenshaw AJ
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(3-4):431-43. PubMed ID: 2664894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Changes in and modulation of receptor activity in hepatic encephalopathy].
    Kienzl E; Riederer P; Brücke T; Kleinberger G; Jellinger K
    Infusionsther Klin Ernahr; 1985 Feb; 12(1):32, 37-45. PubMed ID: 2859245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psychotomimetic N-methylated tryptamines: formation in brain in vivo and in vitro.
    Saavedra JM; Axelrod J
    Science; 1972 Mar; 175(4028):1365-6. PubMed ID: 5059565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of lesions and drugs on brain tryptamine.
    Marsden CA; Curzon G
    J Neurochem; 1974 Dec; 23(6):1171-6. PubMed ID: 4281442
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.